ONCE-WEEKLY BASAL INSULIN FC (BIF) DEMONSTRATED SIMILAR GLYCEMIC CONTROL TO ONCE-DAILY INSULIN DEGLUDEC (DEG) IN INSULIN-NAIVE PATIENTS WITH TYPE 2 DIABETES (T2D)

被引：0
|
作者：
Bue-Valleskey, J. [1 ]
Kazda, C. [1 ]
Ma, C. [1 ]
Chien, J. [1 ]
Zhang, Q. [1 ]
Chigutsa, E. [1 ]
Landschulz, W. [1 ]
Swan, J. [1 ]
Haupt, A. [1 ]
Frias, J. P. [2 ]
机构：
[1] Eli Lilly & Co, Global Sci Commun, Indianapolis, IN USA
[2] Veloc Clin Res, Los Angeles, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
620
引用
收藏
页码：A193 / A193
页数：1
相关论文
共 50 条
  • [21] Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (Sept, 10.7326/M23-1288, 2023)
    Bajaj, H. S.
    Aberle, J.
    Davies, M.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1688 - 1688
  • [22] Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6
    Russell-Jones, D.
    Babazono, T.
    Cailleteau, R.
    Engberg, S.
    Irace, C.
    Kjaersgaard, M. I. S.
    Mathieu, C.
    Rosenstock, J.
    Woo, V.
    Klonoff, D. C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S8
  • [23] Two phase 3 trials of 3-times weekly insulin degludec versus once-daily insulin glargine in insulin-naive people with type 2 diabetes
    DeVries, J. H.
    Ratner, R. E.
    Bode, B. W.
    Russell-Jones, D. L.
    Begtrup, K.
    Johansen, T.
    Zinman, B.
    DIABETOLOGIA, 2012, 55 : S21 - S22
  • [24] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [25] Comparison of biphasic premixed insulin versus once daily basal insulin in insulin-naive veteran patients with type 2 diabetes
    Grisham-Takac, Catlin
    Yeary, Julianne
    Edwards, Krystal
    Chastain, Lisa
    Kelly, Kevin C.
    PHARMACOTHERAPY, 2015, 35 (11): : E259 - E259
  • [26] Once-weekly Basal Insulin Fc versus daily insulin degludec for glycemic control in diabetes: a systematic review, meta-analysis, and meta-regression
    Sandesh Raja
    Adarsh Raja
    Azzam Ali
    Muhammad Sohaib Asghar
    Journal of Diabetes & Metabolic Disorders, 24 (1):
  • [27] CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
    Bergenstal, R.
    Watt, S. Kehlet
    Matos, A. S. A.
    Lingvay, I.
    Mader, J. K.
    Nishida, T.
    Rosenstock, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S397
  • [28] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [29] Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Insulin-Naive Patients With Type 2 Diabetes
    Philis-Tsimikas, Athena
    Del Prato, Stefano
    Satman, Ilhan
    Bhargava, Anuj
    Dharmalingam, Mala
    Skjoth, Trine V.
    Rasmussen, Soren
    Garber, Alan J.
    DIABETES, 2012, 61 : A263 - A263
  • [30] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
12345